A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2004
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1472208A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
11/03/2004	EP1472021A2 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2004	EP1471934A2 Kinases involved in the regulation of energy homeostasis
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471923A1 Amido macrolides
11/03/2004	EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471906A1 Stimulation of cpt-1 as a means to reduce weight
11/03/2004	EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004	EP1471903A2 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
11/03/2004	EP1471897A2 Use of phosphodiesterase antagonists to treat insulin resistance
11/03/2004	EP1383399B1 Nutritional supplement to treat macular degeneration
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004	EP1286957B1 Diphenylmethane derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1206257B1 Use of amino acids for making medicines for treating insulin-resistance
11/03/2004	EP0907360B1 Method for maintaining an existing level of body fat and/or body weight
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	CN1543570A Identifying compounds that modulate interaction of neuronal nitric oxide synthase and its inhibitor, useful e.g. for treating prediabetic states
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1543362A Medical products comprising a haemocompatible coating, production and use thereof
11/03/2004	CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541708A Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals
11/03/2004	CN1541701A Diabetes treating medicine and its preparation
11/03/2004	CN1541692A Medicine for treating diabetes and adjusting blood sugar concentration and its preparation
11/03/2004	CN1541687A Prepared traditional Chinese medicine for treating diabetes
11/03/2004	CN1541672A Diabetes treating Tangke Sanliao Capsule
11/03/2004	CN1541658A Cod-liver oil, royal jelly freeze-dry powder capsule and its process
11/03/2004	CN1541653A Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process
11/03/2004	CN1541646A Hydroxyl methionine salt trace element additive preparation method
11/03/2004	CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004	CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
11/03/2004	CN1173959C 8,8A-dihydro-indeno [1,2-D] thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004	CN1173908C Method for converting derivative of internal inositol of buckwheat seed into its monomer and its seed
11/03/2004	CN1173737C Application of Hepcidin in pharmacy
11/03/2004	CN1173733C Process for preparing dried soybean polypeptide powder with fat reducing action
11/03/2004	CN1173730C Blood fat-regulating medicine composition
11/03/2004	CN1173723C Beautifying and weight reducing product and its preparing process
11/03/2004	CN1173707C Medicinal composition containing baicalin and caffoeoylchinic acid
11/03/2004	CN1173696C Use of sibutramine analogues to lower lipid levels
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/03/2004	CN1173639C Health-care nutrious food for fining down
11/03/2004	CN1173635C Natural tea for curing men's impotence and method for manufacturing the same
11/02/2004	US6812350 Antidiabetic agents; metabolism diseases; hypotensive agents; cardiovascular disorders
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812252 Acylsulfonamide derivatives containing fluorosubstitutedphenylethynyl group having a hypoglycemic effect and free of the side effect
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	CA2296970C Neuropeptide y antagonists
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004	CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092181A1 Heterocyclic mchr1 antagonists
10/28/2004	WO2004092179A1 Spiro derivative, production process, and antioxidant
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004	WO2004092156A1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092146A2 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004	WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004	WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004	WO2004092127A1 Process for the preparation of n-substituted 2-cyanopyrrolidines
10/28/2004	WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	WO2004091867A1 Processing method and processing device
10/28/2004	WO2004091661A1 Remedy for diabetes
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091612A1 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004091599A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol
10/28/2004	WO2004091598A1 Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
10/28/2004	WO2004091587A1 Multiple release anti-diabetic drugs and process of production thereof
10/28/2004	WO2004091486A2 Compounds for the treatment of metabolic disorders
10/28/2004	WO2004078166A3 Use of omega-3-fatty acids in the treatment of diabetic patients
10/28/2004	WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/28/2004	WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r)
10/28/2004	WO2004024094A3 Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004	WO2003077840A3 Method of modulating inflammatory response

1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 1298